MacroGenics Inc — Quarterly Financial Statistics (NASDAQ:MGNX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities -60.16 M38.41 M46.89 M46.98 M30.19 M 162.47 M Cash from investing activities 35.6 M41.47 M9.9 M17.83 M20.37 M 89.57 M Cash from financing activities -68 K155 K282 K69.17 M0 69.61 M Free cash flow -60.75 M37.79 M46.36 M46.27 M29.76 M 160.18 M

Haberler

BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates

MacroGenics hisseleri FDA’nın kısmi klinik durdurma kararıyla düştü

MacroGenics stock falls after FDA places partial clinical hold

Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)

Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes

FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children

Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3

MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates

MacroGenics Inc kazancı $0,68 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

MacroGenics Inc earnings beat by $0.68, revenue topped estimates

MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Stryker (SYK) Q3 Earnings and Revenues Beat Estimates